Mansfield C, Masaquel A, Sutphin J, Weiss ES, Gutierrez ME, Wilson J, Li J, Reyes C. What do patients prioritize in selecting chronic lymphocytic leukemia (CLL) treatments? Presented at the 58th American Society of Hematology (ASH) Annual Meeting and Exposition; December 5, 2016. San Diego, CA. [abstract] Blood. 2016 Dec 2; 128(22):1239. doi: 10.1182/blood.V128.22.1239.1239
Chintakayala PK. Price elasticities and consumer preferences from market data. Presented at the University of Leeds; December 2016.
Wardman M, Chintakayala PK, de Jong G. Values of travel time in Europe: review and meta-analysis. Transp Res Part A Policy Pract. 2016 Dec;94:93-111. doi: 10.1016/j.tra.2016.08.019
Mankowski C, Ikenwilo D, Heidenreich S, Ryan M, Nazir J, Newman C, Watson V. Men's preferences for the treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia: a discrete choice experiment. Patient Prefer Adherence. 2016 Nov 24;10:2407-17. doi: 10.2147/PPA.S112161
Poulos C, Standaert B, Sloesen B, Hauber AB. What motivates mothers to pay for a vaccine against children's diarrhea? Preferences for vaccines against children's diarrheal illness among mothers in Poland and Hungary. Poster presented at the 2016 ISPOR 19th Annual European Congress; October 31, 2016. Vienna, Austria. [abstract] Value Health. 2016 Nov; 19(7):A419.
Poulos C, Curran D, Anastassopoulou A, De Moerlooze L. German travelers' preferences for vaccines against travel-related illnesses. Poster presented at the 2016 ISPOR 19th Annual European Congress; October 31, 2016. Vienna, Austria. [abstract] Value Health. 2016 Nov; 19(7):A419-20.
Mansfield C, Srinivas S, Chen C, Hauber AB, Hariharan S, Matczak E, Sandin R. The effect of information on preferences for treatments of metastatic renal cell carcinoma. Curr Med Res Opin. 2016 Nov;32(11):1827-38. doi: 10.1080/03007995.2016.1211521
Kenter JO, Bryce R, Christie M, Cooper N, Hockley N, Irvine KN, Fazey I, O'Brien L, Orchard-Webb J, Ravenscroft N, Raymond CM, Reed MS, Tett P, Watson V. Shared values and deliberative valuation: future directions. Ecosyst Serv. 2016 Oct;21(Part B):358-71. doi: 10.1016/j.ecoser.2016.10.006
Kenter JO, Jobstvogt N, Watson V, Irvine KN, Chrisstie M, Bryce R. The impact of information, value-deliberation and group-based decision-making on values for ecosystem services: integrating deliberative monetary valuation and storytelling. Ecosyst Serv. 2016 Oct;21(Part B):270-90. doi: 10.1016/j.ecoser.2016.06.006
Mamounas E, Poulos C, Goertz HP, Gonzalez JM, Pugh A, Antao V. Neoadjuvant systemic therapy for breast cancer: factors influencing surgeons' referrals. Ann Surg Oncol. 2016 Oct;23(11):3510-7. doi: 10.1245/s10434-016-5296-y
Hauber AB, Obi EN, Price MA, Whalley D, Chang CL. Patients' self-reported value of avoiding key heart failure outcomes differs based on disease knowledge. Poster presented at the 2016 HFSA 20th Annual Scientific Meeting; September 17, 2016. Orlando, FL.
Galinksy J, Richard S, Morris M. Myeloma patients' self-reported experiences of care and treatment. Cancer Nurs Pract. 2016 Sep 14;15(7):22-6. doi: 10.7748/cnp.2016.e1341
Wakefield JR, Myers K. Social cost benefit analysis for deep sea minerals mining. Mar Policy. 2016 Jun 22. doi: 10.1016/j.marpol.2016.06.018
Vass C, Gray E, Payne K. Discrete choice experiments of pharmacy services: a systematic review. Int J Clin Phar. 2016 Jun;38(3):620-30. doi: 10.1007/s11096-015-0221-1
Mansfield C, Ekwueme DU, Tangka FKL, Brown DS, Smith JL, Guy, Jr GP, Li C, Hauber AB. Preferences for colorectal cancer screening: a latent class analysis. Poster presented at the 2016 Academy Health Annual Research Meeting; June 2016. Boston, MA.
Vass CM, Payne K. What is health economics? Problematising value in stratified medicine. Presented at the Value, Context and Narrative in Medical Epistemology and Health Care Practice Conference; May 4, 2016. Oxford, United Kingdom.
Poulos C. A review of discrete choice experiment studies of preferences for vaccine features. Poster presented at the 2016 ISPOR 21st Annual International Meeting; May 24, 2016. Washington, DC. [abstract] Value Health. 2016 May; 19(3):A220.
Chintakayala VP. Do green attitudes and demographics drive sustainable product consumption? Presented at the CDRC Data Partner Forum, University of Oxford; May 2016.
Gray E, Eden M, Vass C, McAllister M, Louviere J, Payne K. Valuing preferences for the process and outcomes of clinical genetics services: a pilot study. Patient. 2016 Apr;9(2):135-47. doi: 10.1007/s40271-015-0133-0
Poulos C, Kinter E, Yang J-C, Bridges JFP, Posner JD, Reder AT. Patient preferences for injectable treatments for multiple sclerosis in the United States: a discrete-choice experiment. Patient. 2016 Apr;9(2):171-80. doi: 10.1007/s40271-015-0136-x
Mansfield C, Thomas N, Gebben D, Lucas M. Preferences for multiple sclerosis treatments: differences across subgroups of US patients with RRMS. Poster presented at the 68th American Academy of Neurology Annual Meeting; April 2016. Vancouver, Canada.
Mansfield C, Thomas N, Gebben D, Lucas M, Hauber B. Differences in preferences for disease-modifying treatments across subgroups of U.S. patients with relapsing multiple sclerosis. Poster presented at the 2016 AMCP Managed Care & Specialty Pharmacy Annual Meeting; April 19, 2016. San Francisco, CA. [abstract] J Manag Care Pharm. 2016 Apr; 22(4-a):S66.
Porteous T, Ryan M, Bond C, Watson M, Watson V. Managing minor ailments; the public's preferences for attributes of community pharmacies. A discrete choice experiment. PLoS One. 2016 Mar 31;11(3):e0152257. doi: 10.1371/journal.pone.0152257
Poulos C, Kinter E, Yang JC, Bridges JF, Posner J, Gleibner E, Muhlbacher A, Kieseier B. A discrete-choice experiment to determine patient preferences for injectable multiple sclerosis treatments in Germany. Ther Adv Neurol Disord. 2016 Mar;9(2):95-104. doi: 10.1177/1756285615622736.
Mansfield C, Tangka FKL, Ekwueme DU, Smith JL, Guy GP, Li C, Hauber AB. Stated preference for cancer screening: a systematic review of the literature, 1990–2013. Prev Chronic Dis. 2016 Feb 25;13:E27. doi: 10.5888/pcd13.150433
Chintakayala PK. Modelling consumer preferences for sustainable products from aggregate data. Presented at the Center for Decision Research Seminar Series, the University of Leeds; February 2016.
Cleland J, Johnston P, Watson V, Krucien N, Skatun D. What do UK doctors in training value in a post? A discrete choice experiment. Med Educ. 2016 Feb;50(2):189-202. doi: 10.1111/medu.12896
Dickey H, Ikenwilo D, Norwood P, Watson V, Zangelidis A. "Doctor my eyes": a natural experiment on the demand for eye care services. Soc Sci Med. 2016 Feb;150:117-27. doi: 10.1016/j.socscimed.2015.12.037
Wald JS, Vishwanath NS, Shrestha M, Poulos C, Simon L, Vijayakumar G. Supporting diabetes medication understanding and adherence through a health literacy intervention, Meducation, in Kerala, India. In: LaBresh K, editors. Improving outcomes for noncommunicable diseases in low- and middle-income countries. Publication No. Bk-0017-1608 ed. Research Triangle Park: NC. RTI Press Publication; 2016. p.61-78. doi: 10.3768/rtipress.2016.bk.0017.1608
Cooley P, Rogers SM, Poulos C, Scruggs MD, Rineer JI, Wheaton WD, Allaire BT, Wagener DK. Microsimulation models to assess impact of health programs to address obesity and low birth weight in Indonesia. In: K. LaBresh, editors. Improving outcomes for noncommunicable diseases in low- and middle-income countries. Publication No. Bk-0017-1608 ed. Research Triangle Park: NC. RTI Press Publication; 2016. p.35-60. doi: 10.3768/rtipress.2016.bk.0017.1608
Liede A, Fairchild A, Friedman S, Amelio J, Hallett DC, Mansfield CA, Metcalfe KA. Risk-reducing surgery and cancer-related distress among female BRCA1 and BRCA2 mutation carriers. Poster presented at the 2015 San Antonio Breast Cancer Symposium; December 8, 2015. San Antonio, TX.
Poulos C, Kinter E, Posner J, van Beek J. A comparison of stated preferences for injectable disease-modifying treatments for multiple sclerosis: compliant vs. non-compliant patients. Poster presented at the 2015 ISPOR 18th Annual European Congress; November 2015. Milan, Italy.
Chintakayala PK. Overview of consumer behavior modelling. Presented at the University of Leeds; November 2015.
Chintakayala VP. Modelling aggregate choice data for understanding consumer preferences. Presented at the Choice Modelling Center Seminar Series, the University of Leeds; November 2015.
Mansfield CA, Thomas N, Gebben D, Lucas M. US RRMS patient preferences for multiple sclerosis treatments: an online survey. Poster presented at the 2015 ISPOR 18th Annual European Congress; November 2015. Milan, Italy.
Mansfield CA, Sikirica M, Pugh A, Poulos C, Martin AA, Ruiz Moran L, Morano Larragueta R. Patient preferences for attributes of type 2 diabetes mellitus (T2DM) treatments in Spain. Poster presented at the 2015 ISPOR 18th Annual European Congress; November 2015. Milan, Italy.
Vass C, Rigby D, Campbell S, Payne K. Investigating the framing-effects of risk attributes in a discrete choice experiment for a national breast screening programme. Presented at the 37th Annual Meeting of the Society for Medical Decision Making (SMDM); October 19, 2015. St. Louis, MO.
Vass C, Rigby D, Campbell S, Tate K, Stewart A, Payne K. Using eye-tracking methods to investigate the framing of risk attributes in discrete choice experiments. Poster presented at the 37th Annual Meeting of the Society for Medical Decision Making (SMDM); October 18, 2015. St. Louis, MO.
Dickinson KL, Patil SR, Pattanayak SK, Poulos C, Yang JH. Nature's call: impacts of sanitation choices in Orissa, India. Econ Dev Cult Change. 2015 Oct;64(1):1-29.
Hauber AB, Gilsenan A, Juhaeri J, Zhong Y, Noel B. Benefit risk assessment: understanding and using patient preference methodologies. Presented at the 31st ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 2015. Boston, MA.
Liu X, Sarr M, Swanson T. Resistance to the regulation of common water resources in rural Tunisia. Land Econ. 2015 Aug;91:435-59. doi: 10.3368/le.91.3.435
McAteer A, Yi D, Watson V, Norwood P, Ryan M, Hannaford PC, Elliott AM. Exploring preferences for symptom management in primary care: a discrete choice experiment using a questionnaire survey. Br J Gen Pract. 2015 Jul;65(636):e478-88. doi: 10.3399/bjgp15X685705
Kinter E, van Beek J, Christensen K, Poulos C, Posner J, Sabatella G. Preferences of patients with multiple sclerosis for attributes of injectable MS treatments in the United Kingdom and France. Poster presented at the 1st Congress of the European Academy of Neurology; June 20, 2015. Berlin, Germany.
Maitra B, Dandapat S, Chintakayala P. Differences between the perceptions of captive and choice riders toward bus service attributes and the need for segmentation of bus services in urban India. J Urban Plan Dev. 2015 Jun;141(2).
Mansfield C, Viswanathan M, Woodell C, Ohadike YU, Kennedy Lesch LJ, Malveaux FJ. Improving asthma outcomes for children: many paths to progress. Pediatr Allergy Immunol Pulmonol. 2015 Jun;28(2):80-6. doi: 10.1089/ped.2014.0440
Poulos C, Posner J, Hauber AB, Kauf TK, Potashman M, Viscusi ER, Aeder M. Patient preferences for outcomes following abdominal surgery: gI symptom tolerance. Poster presented at the American Society of Colon and Rectal Surgeons 2015 Annual Scientific Meeting; May 2015. Boston, MA.
Mansfield CA, Poulos C, Hackshaw MD, Pugh AL, Jobanputra M. Patient preferences for first-line maintenance treatments for ovarian cancer. Presented at the 2015 ISPOR 20th Annual International Meeting; May 2015. Philadelphia, PA.
Smith VK, Mansfield CA. The design of benefit cost “architecture” for homeland security policy analysis. In: Mansfield C, Smith VK, editors. Benefit-cost analyses for security policies: does increased safety have to reduce efficiency? Cheltenhen: United Kingdom. Edward Elgar Publishing; 2015.
Mansfield CA, Smith VK. Introducing the issues: Meeting the challenges in evaluating homeland security policy. In: Mansfield C, Smith VK, editors. Benefit-cost analyses for security policies: does increased safety have to reduce efficiency? Cheltenhen: United Kingdom. Edward Elgar Publishing; 2015.
Mansfield CA, Smith VK. What we know and what we need to learn. In: Mansfield C, Smith VK, editors. Benefit-cost analyses for security policies: does increased safety have to reduce efficiency? Cheltenhen: United Kingdom. Edward Elgar Publishing; 2015.